LITHIUM is a drug that is used to prevent and treat manic episodes in people who suffer from manic-depressive illness. The cheapest GoodRx pricing for the most common type of lithium ER is roughly $9.00, This is about 67 percent less than the typical retail price of $27.76.
How much does lithium 450 mg cost?
The typical counter price of Lithium Carbonate Er is $38.09 per 100, 450MG Tablet Extended Release, but you can obtain a Lithium Carbonate Er coupon for only $9.00 when you use your SingleCare prescription medicine discount card.
Is lithium medication expensive?
Depending on the drugstore you visit, lithium oral tablet, extended release 300 mg costs roughly $25 for a supply of 100 tablets. Prices are only valid for cash paying consumers and do not apply to insurance programs.
How much does lithium cost in 2021?
No commodity, however, came close to lithium, a soft metal essential for batteries. According to S&P Global, global demand for lithium surpassed supply for the first time in 2021, and the gap is expected to expand as the market for electric vehicles grows. As a result, the price of lithium increased by 437 percent to roughly $43,000 per ton, according to Trading Economics statistics.
How much is lithium per ton?
In 2019, the yearly average U.S. lithium carbonate pricing for big fixed contracts was $13,000 per metric ton, down 24% from 2018. Lithium hydroxide spot prices in China fell from over $15,500 per ton at the start of the year to around $8,000 per ton in December.
Are lithium prices going up?
Covid-19 Travel Insurance Plans at Their Finest “According to S&P Global Platts statistics, seaborne lithium carbonate prices have risen 413 percent since the start of 2021 to $32,600/mt CIF North Asia on Dec. 14, while lithium hydroxide prices have risen 254 percent over the same time to $31,900/mt CIF North Asia.”
Why is the price of lithium falling?
While demand for rare and precious metals used in the construction of electric car batteries remains high, investors are confronted with a unique situation in which prices have dropped to new lows. Lithium, one of the most important metals, has seen its prices fall by more than 40% in the last year, eroding leading manufacturers’ profit margins and wiping off the majority of their share price increases in recent years.
Albemarle (NYSE:ALB), the world’s largest lithium miner, is one of the corporations hardest hurt by dropping lithium prices. With a market capitalization of $6.54 billion, the lithium mining behemoth’s stock has dropped 33.1 percent in the last six months and 55 percent from its 2017 high. This reduction was caused by dropping lithium prices, not by investors having a problem with Albemarle as a firm. As a result, many analysts now believe the stock is undervalued and could be a smart buy right now.
Despite the fact that lithium demand is likely to increase in the next years due to an avalanche of new lithium supplies, the metal’s prices have been declining in 2019 due to an overstock problem caused by an avalanche of new lithium supplies. Since 2017, six new big lithium mines have begun operations in Australia, which is the world’s leading producer of the battery metal with an annual production of 51,000 tons. Chile, the world’s second-largest lithium producer, has opened its doors to foreign businesses looking to explore the resource-rich Atacama salt flat for lithium. Chile’s output has quadrupled in the last two decades, whereas other countries’ production has increased at a similar rate.
As investors rush to more attractive mining industries, financing for junior and senior lithium and cobalt miners has plummeted. The amount of accessible investment capital is used as a barometer for investor confidence, and it has dropped to record lows. Lithium and cobalt miners raised $34 million on public exchanges in the second quarter of 2019, down 96.2 percent from the $801 million raised in the second quarter of 2018. This drop in funding is reflected in new drilling activity, with the number of freshly completed drill holes dropping by more than half since the third quarter of 2018.
Albemarle’s stock has dropped by more than 50% since its peak in 2017, nearly entirely due to the lithium oversupply situation. In reaction to the supply shortage, the company opted to shelve plans to expand its processing capacity by 125,000 tons across all of its facilities. Albemarle now manages two large lithium sites, one in Nevada and the other in Chile’s Salar de Atacama, and has postponed potential expansions into Australia. Albemarle instead intends to cut capital spending by $1.5 billion over the next five years in order to become cash-flow positive by 2021.
While it’s simple to understand why lithium manufacturers’ prospects are bleak in the short term, the silver lining is that the excess will encourage businesses like Albemarle to trim their operational fat and become more efficient. As the manufacturing of electric vehicles continues to grow, demand for lithium is expected to grow exponentially over the next 24 months, catching up to present supply levels.
This appears to portray a positive image for the company, which is currently selling at a 50% discount to last year’s price due to market forces beyond its control. Albemarle has a solid dividend track record, as well as being attractive from a value standpoint, with the company trading at 12 times earnings versus 15 times earnings historically. For the past 25 years, the company has boosted its dividend every year, resulting in a current dividend yield of 2.38 percent.
Albemarle might become one of the best value stocks in the mining business if the company’s management team follows through on its promise to reduce capital expenditures and return to cash flow positive. These two issues have previously stopped investors from purchasing this company’s stock, therefore addressing them is critical. Albemarle may easily become a solid value option for investors looking for exposure to the electric car market if its cash flows and capital expenditures are improved.
Is there a generic lithium?
Is lithium available in a generic form? The drug’s generic name is lithium, or lithium carbonate. It’s also marketed under the names Lithobid and Eskalith.